HEART ATTACK: A study to improve cholesterol care after a heart attack
Part of Heart & circulation, Hormones & metabolism clinical trials.
This trial tests whether a program that uses electronic health records can help people who have had a heart attack lower their LDL (bad) cholesterol more effectively. It aims to improve follow-up care and reduce the risk of future heart problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You live in Alberta, Canada.
- You were recently hospitalized for a heart attack or unstable angina and had a heart catheterization (angiogram).
- You are willing to stay in touch with the study team if you are in the group that receives extra support.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a team-based approach to help people with artery disease (like heart attacks or leg blockages) get their cholesterol to a healthier level. If your LDL is above 70, you may benefit from extra support to manage your medications.
This study tests whether quickly increasing cholesterol-lowering medication can reduce the risk of another heart attack or stroke. It is for people who have heart disease from blocked arteries.
This study tests whether giving extra education to doctors and patients can help improve cholesterol management after a heart-related hospitalization. It aims to see if a simple program can make sure patients get the right testing and treatment for high cholesterol.
This study tests if a team of specialists working together can help people who have had a heart attack lower their bad cholesterol (LDL) more effectively than standard care. It aims to improve long-term heart health.
This study tests a cholesterol-lowering treatment plan for adults admitted for a Type 1 heart attack. It may help your care team choose guideline-based cholesterol goals and treatments after the event.
This study tests whether a clinical pharmacist-led team can help manage LDL cholesterol levels in patients with heart or blood vessel disease. It aims to improve care for people with conditions like coronary artery disease, stroke, or peripheral artery disease.
Hear when a new Hyperlipidemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.